Evaluation of the therapeutic effect of XiaozhongcuyuTang on postoperative anal fistula surgery and its real-world study on wound healing, serum growth factor concentration, and pH value

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400082363

Enrollment

Unknown

Registered

2024-03-27

Start date

2024-04-01

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anal fistula

Interventions

Test group:Treatment of Stains with Xiaozhongcuyu Tang

control group:Physiological saline stain treatment

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ? Conforming to the diagnostic criteria for anal fistula in accordance with the "Diagnostic Efficacy Standards for Traditional Chinese Medicine Diseases"; ? Aged between 18 and 65 years old; ? No previous abnormal anal morphology and function; ? Those who have no contraindications to surgery and agree to surgical treatment; ? Not using other topical drugs related to this disease after surgery; ? Those who can adhere to medical advice and receive regular follow-up visits.

Exclusion criteria

Exclusion criteria: ? Severe heart, brain, liver and kidney diseases, malnutrition, anemia, endocrine disorders, chronic diarrhea, perianal skin diseases, hematopoietic system diseases, rectal prolapse, anorectal neurosis, tumor radiotherapy and chemotherapy, psychiatric patients, and other diseases that cannot tolerate surgery and affect postoperative wound healing Pregnant, menstrual, and lactating women Patients with tuberculosis, cancer, and Crohn's disease; ? Patients with metabolic system diseases such as diabetes that affect wound healing; ? Individuals who are unable to tolerate or allergic to drugs during the medication process, or have scar constitution; ? Those who do not meet the inclusion criteria, fail to undergo follow-up on time, cannot determine the efficacy, or have incomplete information; ? The experimental subjects have poor compliance and did not change their dressing as required, which may affect the drug efficacy.

Design outcomes

Primary

Measure	Time frame
Serum growth factor;	—

Secondary

Measure	Time frame
Integration of postoperative complications;Wound pH value;Wound area;	—

Countries

China

Contacts

Public ContactSha Jingtao

Xi'an Traditional Chinese Medicine Hospital

1045328255@qq.com+86 136 6926 8356

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026